[Diastolic heart failure: are problems in its diagnosis and treatment solvable?].
The paper discusses the problem of chronic heart failure (CHF) in left ventricular diastolic dysfunction - diastolic heart failure (DHF). It considers whether DHF is an independent phenotype or nothing more than a step in the development of systolic heart failure. The results of a number of studies evaluating the efficiency of treatment for DHF with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, spironolactone, and beta-blockers are given. It is concluded that diastolic dysfunction should be necessarily kept in mind on examining patients with CHF.
S N
SN
Tereshchenko
I V
IV
Zhirov
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D054144:Heart Failure, Diastolic / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D018487:Ventricular Dysfunction, Left / Q000503:physiopathology*
D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors